Trondheim, 15 May 2024: In the first quarter, NORBIT recorded revenues of NOK 404.4 million, corresponding to a growth of 7 per cent from the first quarter of 2023.

Vivoryon Therapeutics N.V. to Report Q1 2024 Financial Results and Operational Progress on May 23, 2024

Les Ulis, le 15 mai 2024 à 7H00

Ascom Activity Monitoring is an end-to-end solution for long-term care that monitor and predict a deterioration in the health of residents. Built on top of Ascom SmartSense, this state-of-the-art and fully interoperable software allows the integration of external sensors and monitors movements and wander behavior, detects potential falls, and monitors typical sleep patterns, etc. of long-term care home residents. Active Monitoring also optimizes workflow efficiency for the caregivers while preserving residents' lifestyle, privacy and safety.

ABN AMRO Bank posts net profit of EUR 674 million in Q1 2024


Q1 - Key messages of the quarter

Basel, 15 May 2024 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the FDA approval of its human papillomavirus (HPV) self-collection solution, one of the first available in the United States. Screening for HPV can help identify women who are at risk of developing cervical cancer so that the disease can be found and treated early before cervical cancer has a chance to develop.

Marimekko Corporation, Interim Report, 15 May 2024 at 8.00 a.m.

The Supervisory Board of AS LHV Varahaldus, a subsidiary of AS LHV Group, has decided to recall Management Board member Joel Kukemelk as of 31 July 2024 as mutually agreed. After that the Management Board will consist of two members.

SINGAPORE, May 15, 2024 (GLOBE NEWSWIRE) --  IHH Healthcare, a world-leading integrated healthcare provider, has reinforced its position as Asia’s leading cancer care provider with the official opening of the Mount Elizabeth Proton Therapy Centre in Singapore.

GOOD BIOLOGICAL DEVELOPMENT IN THE FIRST QUARTER OF 2024. PROGRESS IN VAP S&D CONTINUES.

– REBECCA STRONG wins $1M from Rogers, the biggest cash prize in Canadian television history, plus financial advice, courtesy of CIBC, to help realize their ambitions –

TORONTO, May 14, 2024 (GLOBE NEWSWIRE) -- Wallbridge Mining Company Limited (TSX: WM, OTCQB: WLBMF) (“Wallbridge” or the “Company”) announced today that it has acquired 1,487,500 units (each, a “Unit”) of NorthX Nickel Corp. (formerly Archer Exploration Corp.) (“Archer”) (CSE:NIX) (“NorthX”) at a price of $0.24 per Unit for a total purchase price of $357,000, by way of non-brokered private placement (the “Offering”).

MONTREAL, May 14, 2024 (GLOBE NEWSWIRE) -- PyroGenesis Canada Inc. (http://pyrogenesis.com) (TSX: PYR) (OTCQX: PYRGF) (FRA: 8PY), a high-tech company (the “Company” or “PyroGenesis”) that designs, develops, manufactures and commercializes advanced plasma processes and sustainable solutions which are geared to reduce greenhouse gases (GHG) and address environmental pollutants, is pleased to announce its financial and operational results for the first quarter ended March 31^st, 2024.

Transitioning to a pure-play Canadian industrial REIT through accretive development, strategic sales, and targeted acquisitions.

BRISBANE, Australie, 14 mai 2024 (GLOBE NEWSWIRE) --

Le producteur de lithium nord-américain Sayona (ASX :SYA ; OTCQB : SYAXF), annonce la découverte et l’expansion de nouvelles zones minéralisées sur le site du Complexe Lithium Amérique du Nord (LAN) de la société (SYA : 75 % ; Piedmont Lithium : 25 %) au Québec, Canada.

Amid a nationwide shortage of pharmacy staff, the company is addressing critical healthcare facility challenges by automating the safe and secure delivery of medications

TORONTO, May 14, 2024 (GLOBE NEWSWIRE) -- Discovery Silver Corp. (TSX: DSV, OTCQX: DSVSF) (“Discovery” or the “Company”) today announced financial results for the three months ended March 31, 2024 (“Q1 2024”). The Company also provided a summary of key events since the beginning of 2024, including the release on February 20, 2024, of the feasibility study results (the “Feasibility Study” or “Study”) for Discovery’s 100%-owned Cordero silver project (“Cordero” or the “Project”) in Chihuahua State, Mexico. All figures are stated in Canadian dollars unless otherwise noted.

TOKYO and CAMBRIDGE, Mass., May 14, 2024 (GLOBE NEWSWIRE) -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher, “Biogen”) announced today that Eisai has initiated the rolling submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for lecanemab-irmb (U.S. brand name: LEQEMBI^®) subcutaneous autoinjector for weekly maintenance dosing after it was granted Fast Track designation by the FDA. LEQEMBI is indicated for the treatment of Alzheimer’s disease (AD) in patients with Mild Cognitive Impairment (MCI) or mild dementia stage of disease (collectively referred to as early AD).